The potential therapeutic effects of CBD in the WholeLife 0:220 CBD isolate formulation are extensive. A large body of published literature describes the potent anti-inflammatory properties of cannabidiol, which may have potential therapeutic effects in chronic inflammatory conditions or chronic pain.6,7 CBD is also reported to have anxiolytic and neuroprotective properties, with potential therapeutic application in conditions such as anxiety, insomnia, symptoms associated with dementia and other behavioural disorders.6,7 CBD has a long history of use in refractory seizure disorders.⁸

The added terpene blend of myrcene, caryophyllene, limonene and linalool were chosen for their potential individual benefits, and to potentiate the effects of CBD by supporting its delivery to cell receptors (a phenomenon known as the ‘Entourage Effect’).

There is no detectable THC in WholeLife 0:220 CBD Isolate oil, making this product ideal for patients wanting to start or maintain their cannabinoid therapy without the unwanted intoxicating effects of cannabis or THC.